Benzinga | Jul 29, 2021 04:43PM EDT

Travere Therapeutics Q2 EPS $(0.39) Beats $(0.68) Estimate, Sales $54.62M Beat $50.33M Estimate

Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.68) by 42.65 percent. This is a 77.27 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $54.62 million which beat the analyst consensus estimate of $50.33 million by 8.52 percent. This is a 12.78 percent increase over sales of $48.43 million the same period last year.